ATM Expression as a Prognostic Marker in Patients With Advanced Biliary Tract Cancer Treated With First-line Gemcitabine and Platinum Chemotherapy

Conclusion: We demonstrated that ATM loss could be a prognostic marker after platinum-based chemotherapy in patients with advanced EH-CCC.

Source: In Vivo - January 5, 2021 Category: Research Authors: KIM, H., KIM, S. T., YOO, K. H., HONG, J. Y., PARK, Y. S., LIM, H. Y., PARK, J. O. Tags: Clinical Studies Source Type: research